{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T14:34:46Z","timestamp":1793889286840,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000263","name":"Parkinson Society Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00c3\u00a9bec - Sant\u00c3\u00a9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.parkreldis.2013.03.003","type":"journal-article","created":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T08:47:44Z","timestamp":1364892464000},"page":"670-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"title":["Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease \u2013 A randomized study"],"prefix":"10.1016","volume":"19","author":[{"given":"S.","family":"Rios Romenets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Creti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Fichten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bailes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Libman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.B.","family":"Postuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.parkreldis.2013.03.003_bib1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S1389-9457(08)70006-6","article-title":"Insomnia in patients with neurodegenerative conditions","volume":"8","author":"Dauvilliers","year":"2007","journal-title":"Sleep Med"},{"issue":"12 Suppl. 3","key":"10.1016\/j.parkreldis.2013.03.003_bib2","first-page":"S12","article-title":"Sleep issues in Parkinson's disease","volume":"64","author":"Adler","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.parkreldis.2013.03.003_bib3","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1017\/S1355617711001482","article-title":"The impact of sleep quality on cognitive functioning in Parkinson's disease","volume":"18","author":"Stavitsky","year":"2012","journal-title":"J\u00a0Int Neuropsychol Soc"},{"issue":"11","key":"10.1016\/j.parkreldis.2013.03.003_bib4","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/mds.23168","article-title":"Treatment of insomnia in Parkinson's disease: a controlled trial of eszopiclone and placebo","volume":"25","author":"Menza","year":"2010","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.parkreldis.2013.03.003_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","article-title":"Melatonin for sleep disturbances in Parkinson's disease","volume":"6","author":"Dowling","year":"2005","journal-title":"Sleep Med"},{"issue":"3","key":"10.1016\/j.parkreldis.2013.03.003_bib6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s10865-008-9198-8","article-title":"Non-pharmacological treatments for insomnia","volume":"32","author":"Ebben","year":"2009","journal-title":"J\u00a0Behav Med"},{"issue":"1","key":"10.1016\/j.parkreldis.2013.03.003_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1037\/0278-6133.25.1.3","article-title":"Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age","volume":"25","author":"Irwin","year":"2006","journal-title":"Health Psychol"},{"issue":"Suppl.","key":"10.1016\/j.parkreldis.2013.03.003_bib8","first-page":"37","article-title":"Nonpharmacologic treatments of insomnia","volume":"53","author":"Bootzin","year":"1992","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.parkreldis.2013.03.003_bib9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"1\u20132","key":"10.1016\/j.parkreldis.2013.03.003_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1353-8020(99)00011-5","article-title":"A\u00a0review of normal sleep and its disturbances in Parkinson's disease","volume":"5","author":"Pal","year":"1999","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"10.1016\/j.parkreldis.2013.03.003_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4088\/JCP.v69n1005","article-title":"Efficacy and safety of doxepin 1\u00a0mg, 3\u00a0mg, and 6\u00a0mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study","volume":"69","author":"Scharf","year":"2008","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.parkreldis.2013.03.003_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/sleep\/30.11.1555","article-title":"Efficacy and safety of doxepin 1\u00a0mg, 3\u00a0mg, and 6\u00a0mg in adults with primary insomnia","volume":"30","author":"Roth","year":"2007","journal-title":"Sleep"},{"issue":"12","key":"10.1016\/j.parkreldis.2013.03.003_bib13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/mds.22110","article-title":"SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease","volume":"23","author":"Martinez-Martin","year":"2008","journal-title":"Mov Disord"},{"issue":"16","key":"10.1016\/j.parkreldis.2013.03.003_bib14","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1002\/mds.23190","article-title":"Scales to assess sleep impairment in Parkinson's disease: critique and recommendations","volume":"25","author":"Hogl","year":"2010","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.parkreldis.2013.03.003_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1389-9457(00)00065-4","article-title":"Validation of the Insomnia Severity Index as an outcome measure for insomnia research","volume":"2","author":"Bastien","year":"2001","journal-title":"Sleep Med"},{"issue":"6","key":"10.1016\/j.parkreldis.2013.03.003_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/jnnp.73.6.629","article-title":"The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease","volume":"73","author":"Chaudhuri","year":"2002","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.parkreldis.2013.03.003_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.parkreldis.2013.03.003_bib18","first-page":"218","volume":"vol. 218\u2013222","author":"Guy","year":"1976"},{"issue":"4","key":"10.1016\/j.parkreldis.2013.03.003_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.parkreldis.2010.02.001","article-title":"Sleep in Parkinson's disease: a comparison of actigraphy and subjective measures","volume":"16","author":"Stavitsky","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.parkreldis.2013.03.003_bib20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10865-006-9047-6","article-title":"Assessment of sleep hygiene using the Sleep Hygiene Index","volume":"29","author":"Mastin","year":"2006","journal-title":"J\u00a0Behav Med"},{"issue":"11","key":"10.1016\/j.parkreldis.2013.03.003_bib21","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/sleep\/30.11.1547","article-title":"Dysfunctional beliefs and attitudes about sleep (DBAS): validation of a brief version (DBAS-16)","volume":"30","author":"Morin","year":"2007","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.parkreldis.2013.03.003_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1212\/01.WNL.0000055868.06222.AB","article-title":"Effects of fatigue on physical activity and function in patients with Parkinson's disease","volume":"60","author":"Garber","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2013.03.003_bib23","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000058905.71369.97","article-title":"Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness","volume":"60","author":"Merino-Andreu","year":"2003","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.parkreldis.2013.03.003_bib24","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.21333","article-title":"Depression rating scales in Parkinson's disease: critique and recommendations","volume":"22","author":"Schrag","year":"2007","journal-title":"Mov Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.parkreldis.2013.03.003_bib25","first-page":"S10","article-title":"PDQ-39: a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures","volume":"245","author":"Peto","year":"1998","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.parkreldis.2013.03.003_bib26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.parkreldis.2013.03.003_bib27","first-page":"2124","article-title":"Zopiclone: is it a pharmacologic agent for abuse?","volume":"53","author":"Cimolai","year":"2007","journal-title":"Can Fam Physician"},{"issue":"8","key":"10.1016\/j.parkreldis.2013.03.003_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/S1092852900019611","article-title":"Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects","volume":"10","author":"Terman","year":"2005","journal-title":"CNS Spectr"},{"issue":"2","key":"10.1016\/j.parkreldis.2013.03.003_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002826-200303000-00005","article-title":"Study of circadian melatonin secretion pattern at different stages of Parkinson's disease","volume":"26","author":"Bordet","year":"2003","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"10.1016\/j.parkreldis.2013.03.003_bib30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1515\/revneuro-2011-0072","article-title":"A\u00a0historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson's disease","volume":"23","author":"Willis","year":"2012","journal-title":"Rev Neurosci"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013001193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802013001193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:13:57Z","timestamp":1761178437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802013001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1353802013001193"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.03.003","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease \u2013 A randomized study","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2013.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2013 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}